events MACE

Related by string. Events MACE * eventing . EVENTS . EVENT . Events . Eventing . Event . eventer : IN NO EVENT . EVENT GIVING RISE TO . Petersen Events Center . Corporate Event Announcement . event shall AME . shared Events Calendar . SYS CON Events / mace . maces . Maces . Mace : Provost Arnett Mace . Mace Julianna Gehant Catalina . Stephan Mace . Gina Mace . Dr. Mace Rothenberg . Obi Wan Kenobi Mace * *

Related by context. Frequent words. (Click for all words.) 70 myocardial infarction stroke 68 target lesion revascularization 67 myocardial infarction MI 66 target vessel revascularization 66 composite endpoint 66 cytogenetic response 66 events SAEs 66 discontinuations due 65 thromboembolic events 65 events AEs 64 coronary revascularization 64 thromboembolism 64 stroke myocardial infarction 62 thrombotic events 61 CYPHER ® Stent 61 laboratory abnormalities 61 discontinuations 61 bivalirudin 61 myocardial infarctions 61 cardiovascular hospitalization 60 myocardial infarction 60 Secondary endpoints included 60 plus gemcitabine 60 enalapril 60 TAXUS stent 60 stent implantation 59 ST elevation myocardial 59 rosuvastatin 59 mg BID 59 vertebral fracture 59 secondary endpoint 59 P = .# 59 enoxaparin 59 mg QD 59 plus methotrexate 59 plus prednisone 59 LVEF 59 active comparator 58 MACE 58 valsartan 58 FOLFIRI 58 pulmonary embolism PE 58 stent restenosis 58 dacarbazine 58 virologic response 58 TRITON TIMI 58 unfractionated heparin 58 secondary efficacy endpoints 58 TAXUS 58 treatment emergent adverse 58 Secondary endpoints 57 acute myocardial infarction AMI 57 confidence interval CI 57 intracerebral hemorrhage 57 severe renal impairment 57 neoadjuvant 57 annualized relapse 57 Rivaroxaban 57 endarterectomy 57 colectomy 57 median PFS 57 nasopharyngitis 57 Adverse events 57 glimepiride 57 placebo p = 57 febrile neutropenia 57 leukopenia 57 infarction STEMI 57 carotid endarterectomy 57 QTc 57 esomeprazole 56 confidence interval #.#-#.# 56 infarct size 56 abciximab 56 antiplatelet agents 56 DAS# [002] 56 % CI #.#-#.# [006] 56 J Am Coll 56 inflammatory lesions 56 cardiovascular mortality 56 levetiracetam 56 Arch Intern Med 56 QT prolongation 56 cardiac dysfunction 56 dose regimens 56 stable angina 56 vertebral fractures 56 renal insufficiency 56 TIMI 55 CABG 55 left ventricular dysfunction 55 fondaparinux 55 Secondary endpoints include 55 MIs 55 patients receiving ERBITUX 55 p = #.# [004] 55 NYHA class 55 tumor lysis syndrome 55 hsCRP 55 FOLFOX 55 virologic failure

Back to home page